Changes in classification of genetic variants in BRCA1 and BRCA2

被引：0
|
作者：
Karin Kast
Pauline Wimberger
Norbert Arnold
机构：
[1] Technische Universität Dresden,Department of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus
[2] National Center for Tumor Diseases (NCT),Department of Obstetrics and Gynecology, University Hospital of Schleswig–Holstein
[3] Partner Site Dresden,undefined
[4] German Cancer Consortium (DKTK),undefined
[5] Dresden and German Cancer Research Center (DKFZ),undefined
[6] University Kiel,undefined
来源：
Archives of Gynecology and Obstetrics | 2018年 / 297卷
关键词：
Classification; Genetic variant; VUS; BRCA1; BRCA2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：279 / 280
页数：1
相关论文
共 50 条
  • [41] Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants
    Li, Hongyan
    Engel, Christoph
    de la Hoya, Miguel
    Peterlongo, Paolo
    Yannoukakos, Drakoulis
    Livraghi, Luca
    Radice, Paolo
    Thomassen, Mads
    Hansen, Thomas V. O.
    Gerdes, Anne-Marie
    Nielsen, Henriette R.
    Caputo, Sandrine M.
    Zambelli, Alberto
    Borg, Ake
    Solano, Angela
    Thomas, Abigail
    Parsons, Michael T.
    Antoniou, Antonis C.
    Leslie, Goska
    Yang, Xin
    Chenevix-Trench, Georgia
    Caldes, Trinidad
    Kwong, Ava
    Pedersen, Inge Sokilde
    Lautrup, Charlotte K.
    John, Esther M.
    Terry, Mary Beth
    Hopper, John L.
    Southey, Melissa C.
    Andrulis, Irene L.
    Tischkowitz, Marc
    Janavicius, Ramunas
    Boonen, Susanne E.
    Kroeldrup, Lone
    Varesco, Liliana
    Hamann, Ute
    Vega, Ana
    Palmero, Edenir, I
    Garber, Judy
    Montagna, Marco
    Van Asperen, Christi J.
    Foretova, Lenka
    Greene, Mark H.
    Selkirk, Tina
    Moller, Pal
    Toland, Amanda E.
    Domchek, Susan M.
    James, Paul A.
    Thorne, Heather
    Eccles, Diana M.
    GENETICS IN MEDICINE, 2022, 24 (01) : 119 - 129
  • [42] Characterization of BRCA1 and BRCA2 variants in multi- ethnic Asian cohort from a Malaysian case-control study
    Lai, Kah Nyin
    Ho, Weang Kee
    Kang, In Nee
    Kang, Peter Choon Eng
    Phuah, Sze Yee
    Mariapun, Shivaani
    Yip, Cheng-Har
    Taib, Nur Aishah Mohd
    Teo, Soo-Hwang
    BMC CANCER, 2017, 17
  • [43] Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
    Fanale, Daniele
    Fiorino, Alessia
    Incorvaia, Lorena
    Dimino, Alessandra
    Filorizzo, Clarissa
    Bono, Marco
    Cancelliere, Daniela
    Calo, Valentina
    Brando, Chiara
    Corsini, Lidia Rita
    Sciacchitano, Roberta
    Magrin, Luigi
    Pivetti, Alessia
    Pedone, Erika
    Madonia, Giorgio
    Cucinella, Alessandra
    Badalamenti, Giuseppe
    Russo, Antonio
    Bazan, Viviana
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [44] Quantitative Analysis of BRCA1 and BRCA2 Germline Splicing Variants Using a Novel RNA-Massively Parallel Sequencing Assay
    Farber-Katz, Suzette
    Hsuan, Vickie
    Wu, Sitao
    Landrith, Tyler
    Vuong, Huy
    Xu, Dong
    Li, Bing
    Hoo, Jayne
    Lam, Stephanie
    Nashed, Sarah
    Toppmeyer, Deborah
    Gray, Phillip
    Haynes, Ginger
    Lu, Hsiao-Mei
    Elliott, Aaron
    Davis, Brigette Tippin
    Karam, Rachid
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [45] Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants
    Fraile-Bethencourt, Eugenia
    Valenzuela-Palomo, Alberto
    Diez-Gomez, Beatriz
    Infante, Mar
    Duran, Mercedes
    Marcos, German
    Lastra, Enrique
    Gomez-Barrero, Susana
    Velasco, Eladio A.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (01) : 53 - 63
  • [46] Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
    Li, Hongyan
    LaDuca, Holly
    Pesaran, Tina
    Chao, Elizabeth C.
    Dolinsky, Jill S.
    Parsons, Michael
    Spurdle, Amanda B.
    Polley, Eric C.
    Shimelis, Hermela
    Hart, Steven N.
    Hu, Chunling
    Couch, Fergus J.
    Goldgar, David E.
    GENETICS IN MEDICINE, 2020, 22 (04) : 701 - 708
  • [47] Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines
    So, Min-Kyung
    Jeong, Tae-Dong
    Lim, Woosung
    Moon, Byung-In
    Paik, Nam Sun
    Kim, Seung Cheol
    Huh, Jungwon
    BREAST CANCER, 2019, 26 (04) : 510 - 519
  • [48] Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes
    Militello, Anna Maria
    Orsi, Giulia
    Cavaliere, Alessandro
    Niger, Monica
    Avallone, Antonio
    Salvatore, Lisa
    Tortora, Giampaolo
    Rapposelli, Ilario Giovanni
    Giordano, Guido
    Noventa, Silvia
    Giommoni, Elisa
    Bozzarelli, Silvia
    Macchini, Marina
    Peretti, Umberto
    Procaccio, Letizia
    Puccini, Alberto
    Cascinu, Stefano
    Montagna, Cristina
    Milella, Michele
    Reni, Michele
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 92 (6) : 501 - 510
  • [49] GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes
    Caleca, Laura
    Colombo, Mara
    Hansen, Thomas van Overeem
    Lazaro, Conxi
    Manoukian, Siranoush
    Parsons, Michael T.
    Spurdle, Amanda B.
    Radice, Paolo
    CANCERS, 2019, 11 (02):
  • [50] In silico, in vitro and case-control analyses as an effective combination for analyzing BRCA1 and BRCA2 unclassified variants in a population-based sample
    Rodriguez-Balada, Marta
    Roig, Barbara
    Martorell, Lourdes
    Mele, Mireia
    Salvat, Monica
    Vilella, Elisabet
    Borras, Joan
    Guma, Josep
    CANCER GENETICS, 2016, 209 (11) : 487 - 492
12345